Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BRD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CTCF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAG6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTNNA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOSR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPB41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SART1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KBTBD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3R3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCOR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GBA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ILF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUBD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERGEF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPHN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NADK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on